MS8815 N is a negative control of EZH2 PROTAC degrader MS8815 ( HY-148334 ). MS8815 N is incapable of recruiting the VHL E3 ligase but retains the same EZH2 binding moiety and linker. MS8815 N can be used for triple-negative breast cancer (TNBC) research. (Pink: EZH2 ligand ( HY-147230 ); Blue: Ligands for E3 Ligase E3 ligase ligand; Black: linker ( HY-B0704 )).
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Histone Methyltransferase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。